The process of carcinogenesis is complex and not easy to eliminate. It includes the initial occurrence of genetic alterations which can lead to the inactivation of tumor-suppressor genes and further accumulation of genetic alterations during tumor progression. Looking for food and food components with biological properties, collectively called nutraceuticals, that can hinder such alterations and prevent the inactivation of tumor-suppressor genes is a very promising area for cancer prevention. Proteins and peptides are one group of nutraceuticals that show potential results in preventing the different stages of cancer including initiation, promotion, and progression. In this review, we summarized current knowledge on the use of nutraceutical proteins and peptides in cancer prevention and treatment. We focused on the role of plant protease inhibitors, lactoferrin and lactoferricin, shark cartilage, plant lectins, and lunasin in the apoptosis, angiogenesis, and metastasis of cancer cells. Also included are studies on bioavailability and clinical trials conducted on these promising proteins and peptides.
The role of nutraceutical proteins and peptides in apoptosis, angiogenesis, and metastasis of cancer cells.
Please Share This Share this content
- Opens in a new window Twitter
- Opens in a new window Facebook
- Opens in a new window Google+
- Opens in a new window Pinterest
- Opens in a new window LinkedIn
- Opens in a new window Viber
- Opens in a new window VK
- Opens in a new window Reddit
- Opens in a new window Tumblr
- Opens in a new window Viadeo
- Opens in a new window WhatsApp